Flavonoid-mediated tumor growth suppression demonstrated by in vivo study

被引:31
|
作者
Kamei, H
Koide, T
Kojimam, T
Hasegawa, M
Terabe, K
Umeda, T
Hashimoto, Y
机构
[1] AICHI MED UNIV,DEPT SURG 1,NAGAKUTE,AICHI 48011,JAPAN
[2] AICHI GAKUIN UNIV,SCH DENT,DEPT BIOCHEM,NAGOYA,AICHI 464,JAPAN
关键词
flavonoid; anthocyanin; bioflavonoid;
D O I
10.1089/cbr.1996.11.193
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Many of flavonoids as well as bioflavonoids extracted from higher plants, which were earlier revealed to have tumor cell growth suppression activity in vitro, were examined for their effect on tumors in vivo. Balb/c mice were inoculated i.p. with syngeneic tumor cells, meth/a, and then provided with flavonoids dissolved in their drinking water during the course of their survival time. Many flavonoids were effective in prolonging the survival period. Furthermore, flavonoids that did not show suppressive activities in the in vitro experiments were effective in the in vivo assay. The data suggested that sugar bonded to the A ring, which suppresses tumor growth inhibition in vitro, plays an important role. Many aglycones that were effective in the in vitro assay on the tumor growth suppression were not effective in the in vivo assay. The reason for this seems to be that most aglycones are unstable and thus break down in vivo. No acute nor chronic toxicity of flavonoids was observed in the mice.
引用
收藏
页码:193 / 196
页数:4
相关论文
共 50 条
  • [31] Stable RNA interference-mediated suppression of Cyclophilin A diminishes non-small-cell lung tumor growth in vivo
    Howard, BA
    Furumai, R
    Campa, MJ
    Rabbani, ZN
    Vujaskovik, Z
    Wang, XF
    Patz, EF
    CANCER RESEARCH, 2005, 65 (19) : 8853 - 8860
  • [32] Tumor growth suppression in vivo by overexpression of the circadian component, PER2
    Miyazaki, Koyomi
    Wakabayashi, Miyuki
    Hara, Yasuhiro
    Ishida, Norio
    GENES TO CELLS, 2010, 15 (04) : 351 - 358
  • [33] Elucidating flavonoid-mediated ADA2 inhibition through computational analysis: a novel strategy for enhancing immune response in glioma
    Banerjee, S.
    Majumder, R.
    Mukherjee, B.
    Mandal, M.
    FEBS OPEN BIO, 2024, 14 : 107 - 107
  • [34] Suppression of Cell Debris-Stimulated Tumor Growth by Resolvin Mediated Clearance
    Sulciner, Megan
    Mudge, Dayna
    Ramon, Sesquile
    Dalli, Jesmond
    Kieran, Mark
    Huang, Sui
    Serhan, Charles
    Panigrahy, Dipak
    FASEB JOURNAL, 2015, 29
  • [35] Suppression of prostate tumor cell growth in vivo by WT1, the Wilms' tumor suppressor gene
    Fraizer, G
    Leahy, R
    Priyadarshini, S
    Graham, K
    Delacerda, J
    Diaz, M
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2004, 24 (03) : 461 - 471
  • [36] Quantitative Structure-Activity Relationships for the Flavonoid-Mediated Inhibition of P-Glycoprotein in KB/MDR1 Cells
    Xia, Mengmeng
    Fang, Yajing
    Cao, Weiwei
    Liang, Fuqiang
    Pan, Siyi
    Xu, Xiaoyun
    MOLECULES, 2019, 24 (09):
  • [37] SUPPRESSION OF TUMOR GROWTH IN-VIVO INITIATED BY SOLUBLE PRODUCTS OF SPECIFICALLY STIMULATED LYMPHOCYTES
    BERNSTEI.ID
    THOR, DE
    ZBAR, B
    RAPP, HJ
    JOURNAL OF THE RETICULOENDOTHELIAL SOCIETY, 1971, 9 (06): : 614 - &
  • [38] In vivo tumor suppression by adenovirus-mediated interferon α2b gene delivery
    Ahmed, CMI
    Sugarman, BJ
    Johnson, DE
    Bookstein, RE
    Saha, DP
    Nagabhushan, TL
    Wills, KN
    HUMAN GENE THERAPY, 1999, 10 (01) : 77 - 84
  • [39] Suppression of Tumor Growth In vivo by the Mitocan α-tocopheryl Succinate Requires Respiratory Complex II
    Dong, Lan-Feng
    Freeman, Ruth
    Liu, Ji
    Zobalova, Renata
    Marin-Hernandez, Alvaro
    Stantic, Marina
    Rohlena, Jakub
    Valis, Karel
    Rodriguez-Enriquez, Sara
    Butcher, Bevan
    Goodwin, Jacob
    Brunk, Ulf T.
    Witting, Paul K.
    Moreno-Sanchez, Rafael
    Scheffler, Immo E.
    Ralph, Stephen J.
    Neuzil, Jiri
    CLINICAL CANCER RESEARCH, 2009, 15 (05) : 1593 - 1600
  • [40] Adenovirus 5 E1A-mediated tumor suppression associated with E1A-mediated apoptosis in vivo
    Deng, J
    Xia, WY
    Hung, MC
    ONCOGENE, 1998, 17 (17) : 2167 - 2175